Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5299)
All Articles published online
|
Publishing Process of This Article
|
Mar 7, 2013 (publication date) through Apr 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ahmed WH, Furusyo N, Zaky S, Sharaf Eldin A, Aboalam H, Ogawa E, Murata M, Hayashi J. Pre-treatment role of inosine triphosphate pyrophosphatase polymorphism for predicting anemia in Egyptian hepatitis C virus patients. World J Gastroenterol 2013; 19(9): 1387-1395 [PMID: 23538996 DOI: 10.3748/wjg.v19.i9.1387] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i9/1387.htm |
| Number | Citing Articles |
| 1 |
N. Furusyo, E. Ogawa, M. Murata, K. Toyoda, H. Ohnishi, K. Eiraku, M. Shimizu, Y. Harada, F. Mitsumoto, K. Takayama, M. Kainuma, K. Okada, J. Hayashi. Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response. Journal of Antimicrobial Chemotherapy 2014; 69(2): 483 doi: 10.1093/jac/dkt371
|
| 2 |
Frédégonde About, Tiphaine Oudot-Mellakh, Jonathan Niay, Pascaline Rabiéga, Vincent Pedergnana, Darragh Duffy, Philippe Sultanik, Carole Cagnot, Fabrice Carrat, Patrick Marcellin, Fabien Zoulim, Dominique Larrey, Christophe Hézode, Hélène Fontaine, Jean-Pierre Bronowicki, Stanislas Pol, Matthew L. Albert, Ioannis Theodorou, Aurélie Cobat, Laurent Abel, Chen-Hua Liu. Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study. PLOS ONE 2015; 10(12): e0145105 doi: 10.1371/journal.pone.0145105
|
| 3 |
Mohammad Salem Hareedy, Ehab S El Desoky, Jean-Baptiste Woillard, Romany Helmy Thabet, Amany Mohamad Ali, Pierre Marquet, Nicolas Picard. Genetic variants in 6-mercaptopurine pathway as potential factors of hematological toxicity in acute lymphoblastic leukemia patients. Pharmacogenomics 2015; 16(10): 1119 doi: 10.2217/PGS.15.62
|
| 4 |
Ehab S El Desoky, Alaa T Abdelhafez, Jessica Cusato, Sherif I Kamel, Abeer MR Hussein, Amedeo De Nicolo, Giovanni Di Perri, Antonio D'Avolio. The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin‐induced anaemia in chronic hepatitis C Egyptian patients. Clinical and Experimental Pharmacology and Physiology 2017; 44(9): 965 doi: 10.1111/1440-1681.12786
|
| 5 |
Thomas Tu, Keyur Patel, Nicholas A. Shackel. Genomic and Precision Medicine. 2017; : 317 doi: 10.1016/B978-0-12-800685-6.00017-5
|
| 6 |
Antonio D'Avolio, Jessica Cusato, Amedeo De Nicolò, Sarah Allegra, Giovanni Di Perri. Pharmacogenetics of ribavirin-induced anemia in HCV patients. Pharmacogenomics 2016; 17(8): 925 doi: 10.2217/pgs.16.22
|
| 7 |
Hiroaki Ikezaki, Hideyuki Nomura, Norihiro Furusyo, Eiichi Ogawa, Eiji Kajiwara, Kazuhiro Takahashi, Akira Kawano, Toshihiro Maruyama, Yuichi Tanabe, Takeaki Satoh, Makoto Nakamuta, Kazuhiro Kotoh, Koichi Azuma, Kazufumi Dohmen, Shinji Shimoda, Jun Hayashi. Efficacy of interferon‐beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C. Hepatology Research 2016; 46(3) doi: 10.1111/hepr.12555
|
| 8 |
Mohammad Pouryasin, Maryam Keshvari, Heidar Sharafi, Seyed Moayed Alavian, Bita Behnava, Seyed Ehsan Alavian, Ali Pouryasin. The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C. Hepatitis Monthly 2016; 16(2) doi: 10.5812/hepatmon.35278
|
| 9 |
Ahmad Amanzada, Armin D Goralczyk, Lars Reinhardt, Federico Moriconi, Silke Cameron, Sabine Mihm. Erythropoietin rs1617640 G allele associates with an attenuated rise of serum erythropoietin and a marked decline of hemoglobin in hepatitis C patients undergoing antiviral therapy. BMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-503
|
| 10 |
Nicola Coppola, Mariantonietta Pisaturo, Caterina Sagnelli, Lorenzo Onorato, Evangelista Sagnelli. Role of genetic polymorphisms in hepatitis C virus chronic infection. World Journal of Clinical Cases 2015; 3(9): 807-822 doi: 10.12998/wjcc.v3.i9.807
|
| 11 |
Zhichao Ma, Yi Sun, Pengqiang Du, Xingang Li. Association between inosine triphosphatase rs1127354 polymorphisms and ribavirin‐induced anaemia and outcome in hepatitis C virus‐infected patients: A meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 2020; 45(6): 1218 doi: 10.1111/jcpt.13232
|
| 12 |
Nathália Delvaux, Vanessa Duarte da Costa, Maristella Matos da Costa, Livia Melo Villar, Henrique Sérgio Moraes Coelho, Eliane Bordalo Cathalá Esberard, Priscila Pollo Flores, Carlos Eduardo Brandão-Mello, Cristiane Alves Villela-Nogueira, Adilson José de Almeida, Elisabeth Lampe. Inosine triphosphatase allele frequency and association with ribavirin-induced anaemia in Brazilian patients receiving antiviral therapy for chronic hepatitis C. Memórias do Instituto Oswaldo Cruz 2015; 110(5): 636 doi: 10.1590/0074-02760150104
|
| 13 |
Norihiro Furusyo, Eiichi Ogawa, Makoto Nakamuta, Eiji Kajiwara, Hideyuki Nomura, Kazufumi Dohmen, Kazuhiro Takahashi, Takeaki Satoh, Koichi Azuma, Akira Kawano, Yuichi Tanabe, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi. Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C. Journal of Hepatology 2013; 59(2): 205 doi: 10.1016/j.jhep.2013.03.020
|
| 14 |
Maissa El Raziky, Naglaa A. Zayed, Amin Abdel Baki, Shimaa A. Mansour, Rasha M. H. Shahin. ITPA gene polymorphism (94C>A) effects on ribavirin‐induced anemia during therapy in Egyptian patients with chronic hepatitis C. Journal of Medical Virology 2017; 89(10): 1823 doi: 10.1002/jmv.24844
|
| 15 |
Seyed Ehsan Alavian, Heidar Sharafi, Paniz Shirmast, Seyed Moayed Alavian, Bita Behnava, Mohammad Pouryasin, Maryam Keshvari, Ali Pouryasin. A facile PCR‐RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms. Journal of Clinical Laboratory Analysis 2018; 32(7) doi: 10.1002/jcla.22440
|
| 16 |
Daniel Pineda-Tenor, Mónica García-Álvarez, María A. Jiménez-Sousa, Sonia Vázquez-Morón, Salvador Resino. Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0682-y
|
| 17 |
Nader Nemr, Rania Kishk, Mohamed Mandour. Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C. Indian Journal of Gastroenterology 2016; 35(1): 7 doi: 10.1007/s12664-016-0618-3
|
| 18 |
Masayuki Murata, Norihiro Furusyo, Eiichi Ogawa, Fujiko Mitsumoto, Satoshi Hiramine, Hiroaki Ikezaki, Koji Takayama, Motohiro Shimizu, Kazuhiro Toyoda, Mosaburo Kainuma, Jun Hayashi. A case of successful hepatitis C virus eradication by 24 weeks of telaprevir-based triple therapy for a hemophilia patient with hepatitis C virus/human immunodeficiency virus co-infection who previously failed pegylated interferon-α and ribavirin therapy. Journal of Infection and Chemotherapy 2014; 20(5): 320 doi: 10.1016/j.jiac.2013.11.006
|